Ascendis Pharma A/S (ASND) Form 6-K — Jul 15, 2026
Ascendis Pharma A/S granted an aggregate of 14,060 warrants to certain employees on July 14, 2026. Each warrant carries an exercise price of $265.57 per share, which was equal to the closing price of the company's ordinary shares on the grant date. The warrants will vest with 25% on the one-year anniversary of the grant, and the remaining 75% will vest at a rate of 1/36th per month thereafter, subject to continued service. The company amended its Articles of Association to provide for the grant of these warrants.
Key figures
- Warrants Granted
- 14060
- Exercise Price Usd
- 265.57
- Remaining Warrants Available
- 1539503
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.